A novel study on the natural coordination of tooth development in time and space, led by Dr. Han-Sung Jung at the Yonsei University College of Dentistry, Korea, has discovered that “lingual” cells on the side of the tongue form the…
Blog
-

Relationship between hyperinsulinemia and coronary microvascular dis
Introduction
Emerging evidence indicates that a substantial percentage of individuals experiencing ischemic chest pain present with non-obstructive coronary artery pathology upon diagnostic evaluation.1,2 Such clinical cases are increasingly…
Continue Reading
-

How the Mexico City Grand Prix became Formula 1’s ultimate fiesta
Ten years after its triumphant return to the Formula 1 calendar, the Mexico City Grand Prix has become the sport’s ultimate fiesta – a celebration of speed, culture and national pride.
When F1 returned to the Autodromo Hermanos Rodríguez in…
Continue Reading
-
GSK shares fall as narrow approval of blood cancer drug limits US relaunch – Reuters
- GSK shares fall as narrow approval of blood cancer drug limits US relaunch Reuters
- FDA delivers split decision on GSK’s blood cancer drug Blenrep, approving its use in some cases statnews.com
- GSK’s Blenrep’s back in US, but with a narrower label pharmaphorum
- Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD AJMC
- Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma Business Wire
Continue Reading
-
Access Denied
Access Denied
You don’t have permission to access “http://www.business-standard.com/technology/tech-news/openai-acquires-software-applications-ai-startup-by-ex-apple-engineers-behind-workflow-shortcuts-125102400825_1.html” on this…
Continue Reading
-

Development of high-throughput and efficient assay for central nervous
Introduction
Central nervous system (CNS) infections encompass neuroinflammatory conditions triggered by pathogenic invasion of bacteria, viruses, fungi, or parasites into the brain, spinal cord, or meninges, with meningitis, encephalitis,…
Continue Reading
-

Advances in science set to transform treatments for people living with dementia | Department for Science, Innovation & Technology
From blood tests to AI, new ways to diagnose dementia sooner and treat it faster set to be unlocked by new research challenge.
- From blood tests to AI, new ways to diagnose dementia sooner and treat it faster set to be unlocked by new…
Continue Reading
-

F1 ACADEMY expands support for Champions of The Future Academy for 2026
F1 ACADEMY has announced the renewal and expansion of its support for global karting series Champions of The Future Academy (COTFA), with up to 27 young female drivers set to be supported by F1 ACADEMY DISCOVER YOUR DRIVE in 2026.
Since its…
Continue Reading
-

Using bugs to tame urate and advance gout prevention
EIC Bugs4Urate project pioneers living therapies and personalised nutrition to transform early gout prevention and metabolic health.
For centuries, gout has carried an almost mythical image: swollen joints, excruciating pain, and an unfair link…
Continue Reading
-

Procter & Gamble (PG) Q1 2026 earnings
Boxes of Tide Pods dishwasher detergent are displayed at a Costco Wholesale store on July 12, 2025 in San Diego, California.
Kevin Carter | Getty Images News | Getty Images
Procter & Gamble on Friday reported fiscal first-quarter earnings and revenue that beat analysts’ expectations, lifted by higher demand for its beauty and grooming products.
However, the company warned that it expects higher costs from tariffs in fiscal 2026, which began in July. Despite what CEO Jon Moeller called a “challenging consumer and geopolitical environment,” P&G reiterated its forecast for all-in sales and earnings for the fiscal year.
Shares of the company rose about 2% in premarket trading.
Here’s what the company reported for the quarter ended Sept. 30 compared with what Wall Street was expecting, based on a survey of analysts by LSEG:
- Earnings per share: $1.99 adjusted vs. $1.90 expected
- Revenue: $22.39 billion vs. $22.18 billion expected
P&G reported fiscal first-quarter net income attributable to the company of $4.75 billion, or $1.95 per share, up from $3.96 billion, or $1.61 per share, a year earlier.
Excluding items, including costs associated with incremental restructuring, the consumer giant earned $1.99 per share.
Net sales rose 3% to $22.39 billion. Organic sales, which strips out the impact of acquisitions, divestitures and foreign currency, increased 2% in the quarter
P&G’s volume was flat compared with the year-ago period. Volume excludes pricing, which makes it a more accurate reflection of demand than sales.
This story is developing. Please check back for updates.
Continue Reading
